183 related articles for article (PubMed ID: 31989180)
1. Oral propranolol for the treatment of infantile haemangiomas in Singapore.
Tan JMC; Lim HW; Koh MJ
Singapore Med J; 2021 Mar; 62(3):139-142. PubMed ID: 31989180
[TBL] [Abstract][Full Text] [Related]
2. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of propanolol for treatment of infantile haemangioma.
Andersen IG; Rechnitzer C; Charabi B
Dan Med J; 2014 Feb; 61(2):A4776. PubMed ID: 24495884
[TBL] [Abstract][Full Text] [Related]
4. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
6. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
7. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
9. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of haemangiomas of infancy with propranolol; good results, few side effects].
Hermans DJ; Ottenhof MJ; Wijnen MH; van Beynum IM; van der Horst CM; van der Vleuten CJ
Ned Tijdschr Geneeskd; 2011; 155(40):A3482. PubMed ID: 21988755
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
[TBL] [Abstract][Full Text] [Related]
12. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.
Hartmann F; Lockmann A; Grönemeyer LL; Haenssle HA; Zutt M; von Fintel H; Kühnle I; Schön MP; Thoms KM
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1372-1379. PubMed ID: 27911476
[TBL] [Abstract][Full Text] [Related]
13. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
15. Predictors of poor response to oral propranolol in infantile hemangiomas.
Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
[TBL] [Abstract][Full Text] [Related]
16. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
17. Propranolol for the treatment of infantile haemangiomas: our experience with 44 patients.
Lynch M; Lenane P; O'Donnell BF
Clin Exp Dermatol; 2014 Mar; 39(2):142-5. PubMed ID: 24289272
[TBL] [Abstract][Full Text] [Related]
18. Propranolol-resistant infantile haemangiomas.
Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
[TBL] [Abstract][Full Text] [Related]
19. Infantile Hemangioma: A Current Review.
Pahl KS; McLean TW
J Pediatr Hematol Oncol; 2022 Mar; 44(2):31-39. PubMed ID: 34966091
[TBL] [Abstract][Full Text] [Related]
20. [Infantile haemangioma: an update].
Reimer A; Ott H
Hautarzt; 2019 Jun; 70(6):447-458. PubMed ID: 31101924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]